135 related articles for article (PubMed ID: 19415920)
1. Identification of natural MHC class II presented phosphopeptides and tumor-derived MHC class I phospholigands.
Meyer VS; Drews O; Günder M; Hennenlotter J; Rammensee HG; Stevanovic S
J Proteome Res; 2009 Jul; 8(7):3666-74. PubMed ID: 19415920
[TBL] [Abstract][Full Text] [Related]
2. Journey beyond immunology. Regulation of receptor internalization by major histocompatibility complex class I (MHC-I) and effect of peptides derived from MHC-I.
Stagsted J
APMIS Suppl; 1998; 85():1-40. PubMed ID: 9849573
[No Abstract] [Full Text] [Related]
3. Class I major histocompatibility complexes loaded by a periodate trigger.
Rodenko B; Toebes M; Celie PH; Perrakis A; Schumacher TN; Ovaa H
J Am Chem Soc; 2009 Sep; 131(34):12305-13. PubMed ID: 19655751
[TBL] [Abstract][Full Text] [Related]
4. Tetrapeptide derived inhibitors of complexation of a class II MHC: fully unnatural ligands.
Jones AB; Acton JJ; Adams AD; Yuen W; Nichols EA; Schwartz CD; Wicker LS; Hermes JD
Bioorg Med Chem Lett; 1999 Jul; 9(14):2115-8. PubMed ID: 10450992
[TBL] [Abstract][Full Text] [Related]
5. Gold-plating MHC class II molecules.
Roche PA
Nat Chem Biol; 2006 Apr; 2(4):178-9. PubMed ID: 16547476
[No Abstract] [Full Text] [Related]
6. MHC multimer technology: current status and future prospects.
Bakker AH; Schumacher TN
Curr Opin Immunol; 2005 Aug; 17(4):428-33. PubMed ID: 15967654
[TBL] [Abstract][Full Text] [Related]
7. MHC II and the endocytic pathway: regulation by invariant chain.
Landsverk OJ; Bakke O; Gregers TF
Scand J Immunol; 2009 Sep; 70(3):184-93. PubMed ID: 19703008
[TBL] [Abstract][Full Text] [Related]
8. The role of mhc polymorphism in anti-microbial resistance.
Nikolich-Zugich J; Fremont DH; Miley MJ; Messaoudi I
Microbes Infect; 2004 Apr; 6(5):501-12. PubMed ID: 15109966
[TBL] [Abstract][Full Text] [Related]
9. Enrichment of Phosphorylated MHC Peptides with Immobilized Metal Affinity Chromatography and Titanium Dioxide Particles.
Chen R; Li J
Methods Mol Biol; 2019; 2024():259-268. PubMed ID: 31364055
[TBL] [Abstract][Full Text] [Related]
10. Construction of MHC class I-peptide tetrameric complexes for analysis of T-cell-mediated immune responses.
Samuel RV; Hanke T
Methods Mol Med; 2003; 87():279-88. PubMed ID: 12958462
[No Abstract] [Full Text] [Related]
11. ERp57 interacts with conserved cysteine residues in the MHC class I peptide-binding groove.
Antoniou AN; Santos SG; Campbell EC; Lynch S; Arosa FA; Powis SJ
FEBS Lett; 2007 May; 581(10):1988-92. PubMed ID: 17467700
[TBL] [Abstract][Full Text] [Related]
12. A revised model for invariant chain-mediated assembly of MHC class II peptide receptors.
Koch N; McLellan AD; Neumann J
Trends Biochem Sci; 2007 Dec; 32(12):532-7. PubMed ID: 17980601
[TBL] [Abstract][Full Text] [Related]
13. Identification of HLA class II H5N1 hemagglutinin epitopes following subvirion influenza A (H5N1) vaccination.
Zinckgraf JW; Sposato M; Zielinski V; Powell D; Treanor JJ; von Hofe E
Vaccine; 2009 Aug; 27(39):5393-401. PubMed ID: 19596415
[TBL] [Abstract][Full Text] [Related]
14. Generation of peptide-MHC class I complexes through UV-mediated ligand exchange.
Rodenko B; Toebes M; Hadrup SR; van Esch WJ; Molenaar AM; Schumacher TN; Ovaa H
Nat Protoc; 2006; 1(3):1120-32. PubMed ID: 17406393
[TBL] [Abstract][Full Text] [Related]
15. Chemistry of peptides associated with MHC class I and class II molecules.
Rammensee HG
Curr Opin Immunol; 1995 Feb; 7(1):85-96. PubMed ID: 7772286
[TBL] [Abstract][Full Text] [Related]
16. The 1995 Albert Lasker Medical Research Award. The class I and class II proteins of the human major histocompatibility complex.
Strominger JL; Wiley DC
JAMA; 1995 Oct; 274(13):1074-6. PubMed ID: 7563464
[No Abstract] [Full Text] [Related]
17. Evolutionary relationships of the classes of major histocompatibility complex genes.
Hughes AL; Nei M
Immunogenetics; 1993; 37(5):337-46. PubMed ID: 8428767
[TBL] [Abstract][Full Text] [Related]
18. Quantitative analysis of phosphopeptides in search of the disease biomarker from the hepatocellular carcinoma specimen.
Lee HJ; Na K; Kwon MS; Kim H; Kim KS; Paik YK
Proteomics; 2009 Jun; 9(12):3395-408. PubMed ID: 19562805
[TBL] [Abstract][Full Text] [Related]
19. MHC class II molecules activate NFAT and the ERK group of MAPK through distinct signaling pathways in B cells.
Haylett RS; Koch N; Rink L
Eur J Immunol; 2009 Jul; 39(7):1947-55. PubMed ID: 19544309
[TBL] [Abstract][Full Text] [Related]
20. The genes influencing the susceptibility to IDDM in humans.
Faas S; Trucco M
J Endocrinol Invest; 1994; 17(7):477-95. PubMed ID: 7829823
[No Abstract] [Full Text] [Related]
[Next] [New Search]
